← Back to Search

Accelerated medical clearance and surgery for Hip Fracture (HIP ATTACK Trial)

N/A
Waitlist Available
Led By Mohit Bhandari, MD, PhD
Research Sponsored by McMaster University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2, 5, 10 years
Awards & highlights

HIP ATTACK Trial Summary

HIP ATTACK is an international randomized controlled trial of 3000 patients with a hip fracture that requires a surgical intervention. This trial will determine the effect of accelerated medical clearance and accelerated surgery compared to standard care on the 90-day risk of mortality and major perioperative complication (i.e., a composite of mortality, nonfatal myocardial infarction, nonfatal pulmonary embolism, nonfatal pneumonia, nonfatal sepsis, nonfatal stroke, and nonfatal life-threatening and major bleeding).

Eligible Conditions
  • Hip Fracture

HIP ATTACK Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2, 5, 10 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2, 5, 10 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Composite - major perioperative complication
Mortality
Secondary outcome measures
Acute Kidney Injury
All-cause mortality
Cardiac revascularization procedure
+35 more

HIP ATTACK Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Accelerated medical clearance and surgeryExperimental Treatment1 Intervention
Rapid medical clearance with targeted arrival to the operating room within 6 hours of diagnosis of a hip fracture requiring surgical repair.
Group II: Standard surgical careActive Control1 Intervention
Surgical hip fracture repair according to the standard timing.

Find a Location

Who is running the clinical trial?

McMaster UniversityLead Sponsor
883 Previous Clinical Trials
2,594,965 Total Patients Enrolled
2 Trials studying Hip Fracture
3,081 Patients Enrolled for Hip Fracture
Population Health Research InstituteOTHER
155 Previous Clinical Trials
676,911 Total Patients Enrolled
Hamilton Health Sciences CorporationOTHER
368 Previous Clinical Trials
298,000 Total Patients Enrolled
1 Trials studying Hip Fracture
64 Patients Enrolled for Hip Fracture

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~271 spots leftby Apr 2025